Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Comment by biggdoggon Mar 31, 2023 2:42pm
97 Views
Post# 35372449

RE:First I've heard of it....

RE:First I've heard of it....FC is low priority. They need to put every dime into sales. And not just one product to market, but all products to market. FC is done, proven and ready to mine. They will never get FC financed until they prove the economics. That is the strategy the company has been promoting. It is mining 101, the issue with FC is there are no mine analysts, no bankers, no engineers who understand a mining company selling drugs. They need to prove the business and then off to the races. This flow through issue is a mute point, because you can’t piss away a few hundred K on FC to do anything of value, they need to spend millions. The share holder loose nothing, the share holders took the risk and signed the agreements and get reimbursed at the end of the day. The money should 100% be going into building pharma sales with Chinese barite. If they are not doing that, they should all be fired. Sales prove economics which gets everything financed.

<< Previous
Bullboard Posts
Next >>